Showing results (21-30 of 44) with videos related to
Sort By:
Pageof 5
BMC Musculoskeletal Disorders|August 1, 2014
Rheumatologists lack confidence in their knowledge of cannabinoids pertaining to the management of rheumatic complaintsMary-Ann Fitzcharles, Peter A Ste-Marie, Daniel J Clauw, et al.Autoimmunity Reviews|June 15, 2020
Rheumatic immune-related adverse events associated with cancer immunotherapy: A nationwide multi-center cohortJanet Roberts, Daniel Ennis, Marie Hudson, et al.Clinical Medicine Insights. Arthritis and Musculoskeletal Disorders|April 16, 2016
Reduction in Serum Uric Acid May Be Related to Methotrexate Efficacy in Early Rheumatoid Arthritis: Data from the Canadian Early Arthritis Cohort (CATCH)Jason J Lee, Vivian P Bykerk, George K Dresser, et al.Annals of the Rheumatic Diseases|May 17, 2015
The comparative effectiveness of oral versus subcutaneous methotrexate for the treatment of early rheumatoid arthritisGlen S Hazlewood, J Carter Thorne, Janet E Pope, et al.Clinical and Experimental Rheumatology|March 25, 2017
Thresholds for the 28-joint disease activity score (DAS28) using C-reactive protein are lower compared to DAS28 using erythrocyte sedimentation rate in early rheumatoid arthritisBindee Kuriya, Orit Schieir, Daming Lin, et al.Rheumatology (Oxford, England)|January 12, 2017
The effect of rheumatoid arthritis-associated autoantibodies on the incidence of cardiovascular events in a large inception cohort of early inflammatory arthritisLillian J Barra, Janet E Pope, Carol Hitchon, et al.Arthritis Care & Research|November 10, 2015
Efficacy, Tolerability, and Safety of Cannabinoid Treatments in the Rheumatic Diseases: A Systematic Review of Randomized Controlled TrialsMary-Ann Fitzcharles, Peter A Ste-Marie, Winfried Häuser, et al.Arthritis & Rheumatology (Hoboken, N.J.)|March 23, 2026
Validation of International Classification of Diseases (ICD) code-based case definitions of immune checkpoint inhibitor associated inflammatory arthritis from administrative health dataManar Elsayed, Zoe Hsu, Finlay A McAlister, et al.The Journal of Rheumatology|December 16, 2024
Effect of Age on Rheumatic Immune-Related Adverse Events: Experience From the Canadian Research Group of Rheumatology in Immuno-Oncology (CanRIO)Jenny Xiaoyu Li, Marie Hudson, Carrie Ye, et al.Blood Reviews|May 20, 2020
Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromesJames T England, Alym Abdulla, Catherine M Biggs, et al.Pageof 5